 by IVC filters in similar proportions of patients
undergoing catheter-directed or pharmacomechanical
thrombolysis and among those with and without involvement of the IVC. However, it is also clear that
symptomatic PE may occasionally complicate these procedures.87 Given that there are little reliable data regarding the risk of PE with the newer pharmacomechanical
modalities and that filter placement is generally associated with little morbidity (but additional cost), it seems
pr